004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 6,680.00
−2.91%Leverage
- Debt / equity
- 0.38x
- Net debt / equity
- 0.29x
- Debt / assets
- 0.22x
- Debt / EBITDA
- 4.77x
- Net debt / EBITDA
- 3.56x
Liquidity & coverage
- Current ratio
- 1.70x
- Quick ratio
- 1.13x
- Cash ratio
- 0.35x
- Interest coverage
- 2.90x
- EBITDA / interest
- 5.60x
- Working capital
- KRW 46.0B
Cash & dividend
- FCF / debt
- 0.14x
- Cash flow / debt
- 0.21x
- Dividend per share
- KRW 30
- Dividend yield
- 0.4%
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Aug 1, 2026